Tuesday, 29 September 2020


UK trial approves breath test for cancer detection

21 May 2018 | News

The researchers expect that as a first-line diagnostic, the test will help some patients to avoid unnecessary invasive procedures.

Image credit- youtube.com

Image credit- youtube.com

A new clinical trial by the Imperial College London has validated the use of their breath test as a first-line diagnostic to identify oesophageal and gastric cancer.

The test has been designed to detect chemical compounds called volatile organic compounds (VOC), which produce a distinctive smell and can be detected in the patient’s exhaled breath.

According to the researchers the non-invasive test can detect cancer from benign diseases with 85% accuracy. They hope that their test can aid clinicians in deciding if a patient needs further investigations.

The researchers expect that as a first-line diagnostic, the test will help some patients to avoid unnecessary invasive procedures.

The team is working on further improving the test and planning a larger trial to confirm the findings in GP surgeries, where the test is intended to be used. The team also wants to evaluate the test for other cancers.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account